GO:0005385 zinc ion transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005385 defines the molecular function that enables zinc (Zn2+) ions to cross a biological membrane, a process essential for zinc homeostasis and signaling.
• The SLC30A (ZnT) and SLC39A (ZIP) families are the principal mammalian zinc transporters that carry out this activity, with SLC30A1 (ZnT1) being a key exporter.
• Dysregulation of zinc transport is linked to aldosterone-producing adenomas, diabetes, and neurological disorders.
• Zinc transport can be studied using in vitro transport assays, live-cell imaging with genetically encoded sensors, and CRISPR-based genetic models.
• CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of zinc transporters in disease.
• EDITGENE provides comprehensive CRISPR services to accelerate research on zinc ion transmembrane transporter activity and its related genes.
Description
Zinc is an essential trace element that serves as a structural cofactor for thousands of proteins and acts as a signaling ion. The molecular function that moves zinc ions across cellular membranes is annotated as GO:0005385, zinc ion transmembrane transporter activity. This activity is fundamental to maintaining cytosolic and organellar zinc concentrations, which in turn regulate processes ranging from gene expression to immune function. Researchers studying zinc biology rely on this GO term to identify and classify the proteins responsible for zinc flux, such as the SLC30A and SLC39A families. Dysregulation of zinc transport has been implicated in a growing list of human diseases. For example, somatic mutations in SLC30A1, which encodes the zinc transporter ZnT1, cause aldosterone-producing adenomas and primary aldosteronism. Zinc transport also intersects with copper homeostasis in diabetes mellitus, and zinc inhibits cAMP-induced chloride secretion in intestinal epithelial cells via the calcium-sensing receptor. These findings underscore the clinical relevance of understanding how zinc crosses membranes. This article provides a research-grade overview of GO:0005385, covering its definition, mechanism, key genes, disease associations, and the experimental methods used to study it. By integrating authoritative QuickGO annotations with real PubMed literature, we aim to equip researchers with a concise yet comprehensive resource for investigating zinc transport in health and disease.
zinc ion transmembrane transporter activity At A Glance
| GO ID | GO:0005385 |
|---|---|
| GO term | zinc ion transmembrane transporter activity |
| Ontology | molecular_function |
| Definition | Enables the transfer of zinc (Zn) ions from one side of a membrane to the other. |
| Synonyms | cobalt, zinc uptake permease activity; zinc, cadmium, cobalt, nickel, lead-efflux ATPase activity; zinc, cadmium uptake permease activity; zinc, iron permease activity |
| Major function | Transport of zinc ions across biological membranes, essential for zinc homeostasis and signaling. |
| Representative genes | SLC30A1 (ZnT1), SLC30A10, SLC39A (ZIP) family members |
| Related diseases | Primary aldosteronism, diabetes mellitus, neurological disorders |
| Research methods | In vitro zinc transport assays, live-cell imaging, CRISPR screens |
What Is GO:0005385?
GO:0005385, zinc ion transmembrane transporter activity, is a molecular function defined by the Gene Ontology as enabling the transfer of zinc (Zn) ions from one side of a membrane to the other. This activity is carried out by integral membrane proteins that form pores or channels, or that use energy to pump zinc against its concentration gradient. It is distinct from zinc binding, which describes the non-transport interaction with zinc ions. The term encompasses transporters that move Zn2+ across plasma membranes or organellar membranes, thereby controlling zinc availability in different cellular compartments.
Why Is zinc ion transmembrane transporter activity Important in Cell Biology?
Zinc ion transmembrane transporter activity is critical for maintaining cellular zinc homeostasis, which is required for proper protein folding, enzymatic catalysis, and signal transduction. Disruption of this activity leads to zinc imbalance, which has been linked to endocrine tumors, metabolic disorders, and neurodegeneration. Understanding the molecular players and regulatory mechanisms of zinc transport can reveal therapeutic targets and biomarkers for these conditions.
• Maintains cytosolic and organellar zinc concentrations within physiological ranges.
• Supports zinc-dependent signaling pathways, including immune responses and cell proliferation.
• Mutations in zinc transporters cause aldosterone-producing adenomas and primary aldosteronism.
• Zinc transport dysfunction contributes to copper dyshomeostasis in diabetes mellitus.
• Zinc transporters are potential antibacterial targets, as zinc ionophores can disrupt bacterial metal homeostasis.
• Enables the study of metal transport mechanisms using in vitro assays and structural biology.
• Provides a basis for CRISPR screens to identify genes required for zinc tolerance or sensitivity.
• Facilitates the development of genetically encoded sensors for live imaging of zinc dynamics.
Molecular Mechanism of zinc ion transmembrane transporter activity
Substrate Recognition and Binding
In simple terms: The transporter first grabs zinc ions from one side of the membrane.
Zinc transporters recognize Zn2+ ions with high specificity, often coordinating the ion through conserved histidine, aspartate, or cysteine residues within their transmembrane domains. For example, structural elements in the transmembrane and cytoplasmic domains of SLC30A10 are required for its manganese efflux activity, and similar principles apply to zinc transport. The binding site ensures that only zinc (or closely related metals) is transported, preventing unwanted ion leakage.
Conformational Changes and Translocation
In simple terms: The transporter changes shape to push the zinc ion across the membrane.
Upon zinc binding, the transporter undergoes conformational changes that move the ion from the cytoplasmic side to the extracellular or luminal side. This process can be driven by concentration gradients (facilitated diffusion) or by ATP hydrolysis (active transport). The SLC30A family (ZnT) typically functions as Zn2+/H+ exchangers or facilitators, while SLC39A (ZIP) family members mediate zinc influx into the cytoplasm. The exact mechanism varies among families but generally involves alternating access of the binding site to either side of the membrane.
Cofactors and Regulation
In simple terms: Other molecules can help or hinder the transporter's activity.
Zinc transport activity can be modulated by pH, membrane potential, and interacting proteins. For instance, zinc inhibits cAMP-induced Cl- secretion in intestinal epithelial cells via the calcium-sensing receptor, indicating crosstalk between zinc transport and other signaling pathways. Additionally, the activity of some transporters is regulated by post-translational modifications or by the availability of cofactors such as bicarbonate. The SLC30A10 transporter requires specific structural elements for its manganese efflux activity, and mutations in these elements can alter metal selectivity.
Energy Coupling
In simple terms: Some transporters use energy to pump zinc against its gradient.
While many zinc transporters are secondary active transporters that use the proton gradient, some are ATP-powered pumps. The synonym 'zinc, cadmium, cobalt, nickel, lead-efflux ATPase activity' indicates that certain transporters couple ATP hydrolysis to the efflux of zinc and other metals. This energy-dependent mechanism allows cells to maintain low cytoplasmic zinc concentrations even when extracellular zinc is high. The ATPase activity is typically associated with P-type ATPases, which undergo phosphorylation during the transport cycle.
Key Genes Involved in GO:0005385 zinc ion transmembrane transporter activity
The following genes encode proteins that exhibit zinc ion transmembrane transporter activity or are directly involved in its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC30A1 (ZnT1) | Zinc exporter; mutations cause aldosterone-producing adenomas | Somatic mutations identified in primary aldosteronism; target for endocrine research |
| SLC30A10 | Manganese and zinc efflux transporter | Structural elements required for metal efflux; mutations cause hypermanganesemia |
| SLC39A (ZIP) family | Zinc influx transporters | Mediate zinc uptake into cytoplasm; involved in immunity and cancer |
| SLC30A (ZnT) family | Zinc efflux transporters | Maintain zinc homeostasis; targets for antibacterial and anticancer studies |
| SLC30A2 (ZnT2) | Zinc secretion into milk | Role in lactation and mammary gland biology |
| SLC30A3 (ZnT3) | Zinc transport into synaptic vesicles | Implicated in neurotransmission and neurodegeneration |
| SLC30A8 (ZnT8) | Zinc transport in pancreatic beta cells | Associated with type 2 diabetes risk |
| SLC39A1 (ZIP1) | Zinc influx | Regulates cellular zinc levels; potential cancer target |
| SLC39A4 (ZIP4) | Zinc absorption in intestine | Mutations cause acrodermatitis enteropathica |
| SLC39A5 (ZIP5) | Zinc transport in pancreas | Involved in zinc homeostasis and diabetes |
| SLC39A6 (LIV-1) | Zinc influx | Breast cancer progression and metastasis |
| SLC39A7 (ZIP7) | Zinc transport into ER | Essential for B-cell development and immune function |
| SLC39A8 (ZIP8) | Zinc and manganese transport | Associated with inflammatory bowel disease and metal toxicity |
| SLC39A10 (ZIP10) | Zinc influx | Required for B-cell receptor signaling |
| SLC39A14 (ZIP14) | Zinc and manganese uptake | Mutations cause childhood-onset parkinsonism-dystonia |
| MTF1 | Metal-responsive transcription factor | Regulates expression of zinc transporters in response to zinc status |
| COMMD1 | Copper metabolism | Interacts with zinc transporters; links copper and zinc homeostasis |
How Is zinc ion transmembrane transporter activity Regulated?
Zinc ion transmembrane transporter activity is regulated at multiple levels to maintain cellular zinc homeostasis. Transcription of zinc transporter genes is controlled by the metal-responsive transcription factor MTF1, which senses cytosolic zinc levels and activates genes such as SLC30A1 and metallothioneins. Post-translational regulation includes phosphorylation, ubiquitination, and protein-protein interactions that alter transporter localization or activity. For example, the activity of SLC30A10 is dependent on specific structural elements, and mutations can disrupt its efflux function. Additionally, zinc transport can be modulated by extracellular signals; zinc inhibits cAMP-induced chloride secretion in intestinal epithelial cells via the calcium-sensing receptor, illustrating crosstalk with GPCR signaling. In disease contexts, somatic mutations in SLC30A1 alter zinc transport and lead to aldosterone overproduction, highlighting the importance of tight regulation.
zinc ion transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC30A1 | Primary aldosteronism; aldosterone-producing adenomas | Knock-in of somatic mutations in adrenal cell lines; KO in mouse models |
| SLC30A8 | Type 2 diabetes; insulin secretion | Point mutation knock-in in beta cells; overexpression in INS-1 cells |
| SLC39A14 | Parkinsonism-dystonia; manganese accumulation | Knockout in neurons; knock-in of patient mutations |
| SLC30A3 | Epilepsy; Alzheimer's disease; synaptic zinc | Knockout mice; tagged knock-in for live imaging |
| SLC39A4 | Acrodermatitis enteropathica; zinc deficiency | Knockout in intestinal epithelial cells; overexpression of wild-type and mutant |
Primary Aldosteronism and Adrenal Tumors
Somatic mutations in SLC30A1, which encodes the zinc transporter ZnT1, cause aldosterone-producing adenomas and primary aldosteronism. These mutations alter zinc transport activity, leading to increased aldosterone synthase expression and autonomous aldosterone production. This discovery links zinc homeostasis directly to endocrine tumorigenesis and provides a rationale for targeting zinc transporters in adrenal disease.
Diabetes Mellitus and Metabolic Disorders
Zinc transport is critical for insulin synthesis, storage, and secretion in pancreatic beta cells. The zinc transporter SLC30A8 (ZnT8) is a risk gene for type 2 diabetes, and copper dyshomeostasis in diabetes mellitus intersects with zinc metabolism. Altered zinc transporter activity can impair glucose-stimulated insulin secretion, contributing to hyperglycemia. Thus, zinc ion transmembrane transporter activity is a key node in metabolic disease research.
Neurological Disorders
In the brain, zinc is stored in synaptic vesicles and released during neurotransmission. The transporter SLC30A3 (ZnT3) loads zinc into these vesicles, and its dysfunction has been implicated in epilepsy and Alzheimer's disease. Mutations in SLC39A14, a zinc and manganese transporter, cause childhood-onset parkinsonism-dystonia due to manganese accumulation. These examples highlight the importance of zinc transport in neuronal health and disease.
Infectious Disease and Antibacterial Targets
Zinc ionophores with antibacterial activity exploit zinc transport mechanisms to disrupt bacterial metal homeostasis. By interfering with zinc efflux or influx, these compounds can inhibit bacterial growth. Understanding zinc ion transmembrane transporter activity in pathogens may lead to new antibiotics, especially against drug-resistant strains.
From zinc ion transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC30A1 affect aldosterone production? | CRISPR knockout in HAC15 or primary adrenal cells |
| How do point mutations in SLC30A1 alter zinc transport? | Point mutation knock-in using CRISPR in cell lines |
| Can we visualize zinc transport in live cells? | Tagged knock-in of SLC30A1 with fluorescent protein; live imaging |
| What is the effect of SLC30A8 overexpression on insulin secretion? | Overexpression in pancreatic beta cell lines |
| Which genes are essential for zinc tolerance? | Genome-wide CRISPR library screening |
| How does SLC39A14 mutation affect manganese homeostasis? | Knock-in of patient mutations in iPSC-derived neurons |
How to Study the zinc ion transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro zinc transport assay | Zinc flux across membrane vesicles | Characterizing transporter kinetics and specificity |
| Live-cell imaging with zinc sensors | Intracellular zinc dynamics | Monitoring transport in real time |
| CRISPR knockout screening | Genes required for zinc tolerance | Identifying novel regulators of zinc homeostasis |
| Site-directed mutagenesis | Effect of mutations on transport activity | Mapping functional domains |
| RNA-seq | Transcriptional changes in response to zinc | Identifying zinc-regulated genes |
| Proteomics | Protein interactions and modifications | Discovering transporter complexes |
| Electrophysiology | Ion currents mediated by transporters | Measuring electrogenic zinc transport |
| Fluorescence microscopy | Subcellular localization of transporters | Determining organelle-specific transport |
In Vitro Zinc Transport Assays
In vitro zinc transport assays using purified membrane vesicles or reconstituted proteoliposomes allow direct measurement of zinc ion transmembrane transporter activity. These assays typically use radioactive zinc (65Zn) or fluorescent zinc indicators to track transport across membranes. They are essential for characterizing the kinetics, substrate specificity, and inhibitor sensitivity of zinc transporters.
Live-Cell Imaging with Genetically Encoded Sensors
Genetically encoded zinc sensors, such as those based on fluorescent proteins, enable real-time monitoring of zinc dynamics in living cells. For example, a novel genetically encoded biosensor has been used for live imaging of intra-lysosome pH, and similar approaches can be adapted for zinc. These tools allow researchers to visualize zinc transport in specific organelles and to study how mutations affect transport activity in situ.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate zinc homeostasis or are required for cell survival under zinc stress. Such screens have been used to discover zinc ionophores with antibacterial activity, highlighting the power of CRISPR to uncover new components of zinc transport pathways. Screens can be performed in various cell types, including cancer and immune cells.
Structural Biology and Mutagenesis
Structural studies of zinc transporters, combined with site-directed mutagenesis, reveal the molecular determinants of zinc binding and translocation. For instance, structural elements in SLC30A10 required for manganese efflux have been mapped by mutagenesis. Similar approaches can be applied to zinc transporters to understand their mechanism and to predict the impact of disease-associated mutations.
How CRISPR Can Be Used to Study GO:0005385 zinc ion transmembrane transporter activity
Knockout
CRISPR knockout of zinc transporter genes, such as SLC30A1 or SLC39A14, allows researchers to study the consequences of loss of function on cellular zinc homeostasis and disease phenotypes. For example, knockout of SLC30A1 in adrenal cells can reveal its role in aldosterone production. Knockout models are also valuable for validating hits from CRISPR screens.
Point Mutation
Point mutation knock-in using CRISPR can recreate disease-associated mutations in zinc transporters. Somatic mutations in SLC30A1 found in aldosterone-producing adenomas can be introduced into cell lines to study their effects on zinc transport and aldosterone synthesis. This approach provides a precise model for understanding how specific amino acid changes alter transporter function.
Knock-in
Knock-in of tagged versions of zinc transporters, such as fluorescent protein fusions, enables live-cell imaging and proteomic studies. Tagged SLC30A1 or SLC39A14 can be used to track localization and dynamics in response to zinc signals. Knock-in of reporter genes under the control of zinc-responsive promoters can also monitor transcriptional responses.
Overexpression
Overexpression of wild-type or mutant zinc transporters using CRISPR activation or lentiviral vectors can test gain-of-function effects. For instance, overexpression of SLC30A8 in beta cells can enhance zinc storage and affect insulin secretion. Overexpression models are useful for studying transporter regulation and for screening inhibitors.
How EDITGENE Supports zinc ion transmembrane transporter activity Research
Researchers studying zinc ion transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in zinc homeostasis or disease. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling functional validation of zinc transporters and their mutants.
Contact EDITGENE today to design your custom CRISPR model for zinc ion transmembrane transporter activity research.
Frequently Asked Questions About zinc ion transmembrane transporter activity
What is zinc ion transmembrane transporter activity?
Zinc ion transmembrane transporter activity (GO:0005385) is a molecular function that enables the transfer of zinc ions across a biological membrane, as defined by the Gene Ontology.
What genes are involved in zinc ion transmembrane transporter activity?
Key genes include SLC30A1 (ZnT1), SLC30A10, and members of the SLC39A (ZIP) family, which encode proteins that transport zinc across membranes.
How is zinc ion transmembrane transporter activity regulated?
It is regulated transcriptionally by metal-responsive transcription factor MTF1, post-translationally by modifications, and through interactions with signaling pathways such as calcium-sensing receptor signaling.
What diseases are associated with zinc transport dysfunction?
Dysfunction is linked to primary aldosteronism, diabetes mellitus, neurological disorders like parkinsonism-dystonia, and infectious diseases.
What methods are used to study zinc ion transmembrane transporter activity?
Common methods include in vitro zinc transport assays, live-cell imaging with genetically encoded sensors, CRISPR screens, and structural biology.
Can CRISPR be used to study zinc transporters?
Yes, CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models are widely used to dissect the roles of zinc transporters in health and disease.
What is the role of SLC30A1 in disease?
Somatic mutations in SLC30A1 cause aldosterone-producing adenomas and primary aldosteronism by altering zinc transport and increasing aldosterone production.
How does zinc affect intestinal chloride secretion?
Zinc inhibits cAMP-induced chloride secretion in intestinal epithelial cells via the calcium-sensing receptor, indicating crosstalk between zinc transport and ion secretion.
What are zinc ionophores and how do they relate to transport?
Zinc ionophores are small molecules that transport zinc across membranes; some have antibacterial activity by disrupting bacterial metal homeostasis.
Why is zinc transport important for neuronal function?
Zinc is stored in synaptic vesicles and released during neurotransmission; transporters like SLC30A3 (ZnT3) are essential for this process, and their dysfunction is implicated in epilepsy and Alzheimer's disease.
Conclusion
Zinc ion transmembrane transporter activity (GO:0005385) is a fundamental molecular function that maintains cellular zinc homeostasis and supports diverse physiological processes. The SLC30A and SLC39A families are central players, and their dysfunction is increasingly linked to human diseases such as primary aldosteronism, diabetes, and neurodegeneration. Advances in CRISPR-based models, live-cell imaging, and structural biology are accelerating our understanding of these transporters. EDITGENE's comprehensive CRISPR services empower researchers to dissect the causal roles of zinc transporters and to develop novel therapeutic strategies.
References
- 1. Rege J et al.. 2023. Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.. Nat Genet 55(10):1623-1631 PMID: 37709865
- 3. Ponsford AH et al.. 2021. Live imaging of intra-lysosome pH in cell lines and primary neuronal culture using a novel genetically encoded biosensor.. Autophagy 17(6):1500-1518 PMID: 32515674
- 4. Yottasan P et al.. 2025. Zinc inhibits cAMP-induced Cl(-) secretion in intestinal epithelial cells via calcium-sensing receptor.. Am J Physiol Cell Physiol 329(5):C1550-C1559 PMID: 41051948
- 5. Dey S et al.. 2023. Quinoline Thiourea-Based Zinc Ionophores with Antibacterial Activity.. J Med Chem 66(16):11078-11093 PMID: 37466499
- 6. Ben Yosef TE et al.. 2023. Characterizing Mammalian Zinc Transporters Using an In Vitro Zinc Transport Assay.. J Vis Exp PMID: 37335097
- 7. Lowe J et al.. 2017. Dissecting copper homeostasis in diabetes mellitus.. IUBMB Life 69(4):255-262 PMID: 28276155
- 8. Zogzas CE et al.. 2016. Structural Elements in the Transmembrane and Cytoplasmic Domains of the Metal Transporter SLC30A10 Are Required for Its Manganese Efflux Activity.. J Biol Chem 291(31):15940-57 PMID: 27307044
